Quintiles News

Please select a press release from the list below, or filter and sort to find a specific press release.

Latest Press Release

Investigator Initiated Trials is Topic of New Handbook Sponsored by Quintiles

SEOUL – January 23, 2015 – Quintiles today announced the launch of a handbook to guide physicians in the conduct of investigator initiated clinical trials. Top clinical researchers from academia and industry across Asia-Pacific joined Quintiles’ experts in contributing to and editing the handbook, which Quintiles sponsored as part of its ongoing efforts to enhance clinical research globally and create a healthier world. Availability of the handbook, “Investigator... Learn More
Published Date: All 2015 2014 2013 2012 2011 2010
Press Release Jan 22, 2015
SEOUL – January 23, 2015 – Quintiles today announced the launch of a handbook to guide physicians in the conduct of investigator initiated clinical trials. Top clinical researchers from academia and industry across Asia-Pacific joined Quintiles’ experts in contributing to and editing the handbook, which Quintiles sponsored as part of its ongoing efforts to enhance clinical research globally and create a healthier world. Availability of the handbook, “Investigator Initiated Trials Made Easy,” was announced at a press conference held at Seoul National University Hospital in South Korea. “Investigator initiated, patient-focused clinical trials play a vital role in improving and expanding patient care in the real world,” said Dr. Stephanie Tan, MBBS, Quintiles Site and Patient Network, Asia,...
Read More
Press Release Jan 19, 2015
RESEARCH TRIANGLE PARK, N.C. – January 19, 2015 – Quintiles Transnational Holdings Inc. (NYSE: Q) will release its fourth-quarter 2014 financial results Thursday, February 12, 2015 prior to its quarterly earnings call at 8:00 a.m. EST. The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call. An archived edition of the conference call will be available online at www.quintiles.com/investors after 1:00 p.m. EST on Thursday, February 12th. About Quintiles Quintiles (NYSE: Q), a Fortune 500 company, is the...
Read More
Press Release Jan 15, 2015
RESEARCH TRIANGLE PARK, N.C. – January 15, 2015 – Expression Analysis (EA), a Quintiles company, today announced the winners of a grant program that provides scientists with leading-edge products and services to advance genomics research. In this sixth year of the program, EA and co-sponsor, Illumina, awarded two fully funded research grants to investigate genomic data locked within Formalin-Fixed, Paraffin Embedded (FFPE) tumor samples – a largely untapped data pool that can help enhance researchers’ understanding of cancer biology.  After a rigorous review of nearly 700 submissions by a distinguished panel of judges, two researchers were selected to receive grants. The recipients include: Professor Anne Bowcock, Ph.D., chair of Cancer Genomics at Imperial College London, who will...
Read More
Press Release Dec 17, 2014
RESEARCH TRIANGLE PARK, N.C. – December 17, 2014 – Quintiles CEO Tom Pike will present at the 2015 J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 in San Francisco at the Westin St. Francis Hotel. The Quintiles presentation will begin at 9:00 a.m. PST. Investors may access a live audio webcast of the presentation on the Quintiles’ Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day. About Quintiles Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s...
Read More
Press Release Dec 08, 2014
SINGAPORE – December 9, 2014 – For the sixth time in eight years, Quintiles has been named Asia-Pacific Contract Research Organization of the Year by Frost & Sullivan, a leading business research and consulting firm. The award honors the CRO that scores the highest in Frost & Sullivan’s evaluation of several performance categories, including customer service; price/performance value; pioneering best practices; and addressing unmet needs. Frost & Sullivan cited Quintiles’ local market knowledge; its Asia-Pacific capabilities that complement its global offering; and its ability to provide solutions to meet customers’ most pressing needs as some of the reasons why Quintiles was selected as 2014 CRO of the Year. “I’d like to thank our 10,000 employees across Asia-Pacific for their efforts –...
Read More
Press Release Dec 04, 2014
RESEARCH TRIANGLE PARK, N.C.  – December 4, 2014 – Quintiles today announced that the company was awarded “Best Contract Research Organization” at the annual SCRIP Awards for the third year in-a-row. This is the company’s fourth award received in this category in the last five years. The SCRIP Awards acknowledge excellence in the biopharmaceutical industry, based on judging by an independent panel of 12 life sciences experts. “Our judges felt Quintiles was a worthy winner of the Best Contract Research Organization trophy for the third year in a row,” said Mike Ward, global director of content for IBI Pharma News & Datamonitor Healthcare.  “In the qualifying year, Quintiles once again demonstrated a series of performance milestones in its quest to improve its customers' probability of...
Read More
Press Release Dec 01, 2014
RESEARCH TRIANGLE PARK, N.C. – Dec. 1, 2014 – Quintiles today announced a new offering that combines its industry-leading pharmacovigilance, regulatory dossier/label maintenance, benefit-risk management, and analytic expertise into one integrated solution. This solution will help biopharmaceutical companies better manage all activities required to maintain the licenses for their portfolio of marketed products.  Underpinned by a fully-integrated technology platform, the new offering, called Marketed Product Maintenance (MPM), will provide biopharmaceutical companies with greater data-driven insights on the benefit-risk profiles of their products. These enhanced insights will enable customers to identify potential product risks, fulfill increasingly complicated regulatory requirements and...
Read More
Press Release Nov 19, 2014
SEOUL, SOUTH KOREA – November 19, 2014 – Quintiles announced today that it has been recognized as one of South Korea’s Best Workplaces by the Great Place to Work® Institute. This is Quintiles Korea’s first time to receive the award; it joins many other Quintiles’ offices worldwide similarly honoured by the Great Place to Work Institute. Quintiles Korea was a “Grand Award” winner – the highest level – from among more than 100 companies in South Korea that participated in this year’s study. The Great Place to Work Institute annual ranking is a comprehensive study of organizational culture and also the world’s largest and most respected study of workplace excellence and people management practices. MiSook Hyun, General Manager of Quintiles Korea, said: “This award affirms our efforts to...
Read More
Press Release Nov 07, 2014
RESEARCH TRIANGLE PARK, NC – November 7, 2014 – Quintiles CEO Tom Pike will present at the Credit Suisse Healthcare Conference on Tuesday, November 11, 2014 in Phoenix at the Arizona Biltmore. The Quintiles presentation will begin at 10:00 a.m. (MST). Investors may access a live audio webcast of the presentation on the Quintiles’ Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day. About Quintiles Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling...
Read More
Press Release Nov 04, 2014
RESEARCH TRIANGLE PARK, N.C. – November 4, 2014 – Quintiles Transnational Holdings Inc. (“Quintiles”) (NYSE: Q) announced today the launch of an underwritten, secondary public offering of 13,303,666 shares of its common stock by certain of its existing shareholders, including investment funds associated with Bain Capital Investors, LLC, affiliates of TPG Global, LLC, affiliates of 3i Corporation and Dennis Gillings, CBE, and his affiliates (the “Selling Shareholders”), of which Quintiles intends to repurchase from the underwriter a number of shares having an aggregate value of approximately $250 million. Quintiles is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the Selling Shareholders in this offering.  Quintiles’ per-share...
Read More
Press Release Oct 30, 2014
Research Triangle Park, NC – October 30, 2014 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) today reported its financial results for the third quarter ended September 30, 2014. 13.8% consolidated service revenue growth - Integrated Healthcare Services segment grew service revenues by 32.6% compared to the third quarter of 2013 Consolidated book-to-bill ratio of 1.42 results from 12.8% growth in net new business compared to the third quarter of 2013 Third quarter diluted adjusted EPS increased 22.6% to $0.65 per share compared to the third quarter of 2013 Third quarter GAAP reported diluted EPS increased 42.0% to $0.71 per share compared to the third quarter of 2013 Adjusted full year 2014 service revenue guidance of...
Read More
Press Release Oct 28, 2014
HOUSTON – October 28, 2014 – Modern Healthcare has ranked Encore, A Quintiles Company (formerly Encore Health Resources), in the top 10 of the publication’s 100 Best Places to Work in Healthcare for healthcare suppliers. Encore, a leader in the health-information analytics and technology consulting services focused on healthcare providers, has been recognized on this coveted list every year since the company began operations in 2009. “I am tremendously proud of the company and our employees who truly make Encore a great place to work,” said Dana Sellers, CEO, Encore, A Quintiles Company. “This ranking is particularly special because it’s based almost entirely on information from our own staff – the people who have rolled up their sleeves, done great work for our clients and have helped...
Read More
Press Release Oct 14, 2014
RESEARCH TRIANGLE PARK, NC – October 14, 2014 – Quintiles today announced that the company was awarded the Society for Clinical Research Sites’ (SCRS) 2014 Clinical Research Organization (CRO) Eagle Award. The award, which recognizes outstanding leadership, professionalism, integrity, passion and dedication, was presented during the annual SCRS Site Solutions Summit. "It is such an honor to be recognized again and receive this award for the second year in a row,” said Lindy Jones, senior vice president, Integrated Site Services, Quintiles. “Our ambition of transforming clinical development and accelerating pipelines to achieve better patient outcomes is only possible through the dedication and hard work of our investigators and sites. I would like to thank the investigators who voted for...
Read More
Press Release Sep 30, 2014
RESEARCH TRIANGLE PARK, N.C. – September 30, 2014 – Quintiles Transnational Holdings Inc. (NYSE: Q) will release its third-quarter 2014 financial results Thursday, October 30, 2014 prior to its quarterly earnings call at 8:00 a.m. EDT. The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call. An archived edition of the conference call will be available online at www.quintiles.com/investors after 1:00 p.m. EDT on Thursday, October 30th. About Quintiles Quintiles (NYSE: Q), a Fortune 500 company, is the...
Read More
Press Release Sep 12, 2014
RESEARCH TRIANGLE PARK, N.C. – September 12, 2014 – Recognizing the critical role that emerging biopharmaceutical companies play in the global marketplace, Quintiles today expanded its solution set with the launch of the Quintiles Emerging Biopharma Solution – a new offering designed to meet the unique clinical development needs and goals of these companies. “Emerging biopharmaceutical companies have been important Quintiles customers throughout our 30+ year history, and we understand the unique challenges they face,” said Paula Brown Stafford, president of Clinical Development at Quintiles. “This new offering focuses squarely on those challenges – combining an operational model designed to meet these customers’ needs with access to Quintiles’ global infrastructure, integrated technology...
Read More
Press Release Aug 19, 2014
RESEARCH TRIANGLE PARK, NC – August 19, 2014 – Expression Analysis (EA), a Quintiles company, today announced that it is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research. In the sixth year of the grant program, EA and co-sponsor, Illumina, will award two fully funded oncology research grants. Each grant will enable winners to investigate genomic data locked within Formalin-Fixed, Paraffin Embedded (FFPE) tumor samples - focusing on a largely untapped data pool in an effort to enhance researchers’ understanding of cancer biology. “Our grant program offers motivation, encouragement and resources to researchers who share our commitment to identify genetic factors that influence health and disease,” said Steve McPhail,...
Read More
Press Release Aug 18, 2014
HOUSTON – August 18, 2014 – For the fifth consecutive year, Modern Healthcare has named Encore, A Quintiles Company (formerly Encore Health Resources), one of the Best Places to Work in Healthcare. Encore, a leader in the health-information analytics and technology consulting services focused on healthcare providers, has been recognized on this coveted list every year since the company began operations in 2009. The Best Places to Work in Healthcare award is based on employee survey results and recognizes outstanding employers in the healthcare industry on a national level. “I am once again honored to receive Modern Healthcare’s Best Places to Work in Healthcare award,” said Dana Sellers, CEO, Encore, A Quintiles Company. “The award is confirmation that the combination of open...
Read More
Press Release Jul 31, 2014
Research Triangle Park, NC, July 31, 2014 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) today reported its financial results for the second quarter ended June 30, 2014. 9.7% consolidated service revenue growth - Integrated Healthcare Services segment grew service revenues by 15.6% compared to the second quarter 2013 21.2% net new business growth compared to the second quarter 2013 representing a book-to-bill ratio of 1.19 Second quarter diluted adjusted EPS increased 30% to $0.65 per share compared to the second quarter of 2013 Second quarter GAAP reported diluted EPS increased 113% to $0.64 per share compared to the second quarter of 2013 Increased full year 2014 service revenue guidance to $4.20 billion - $4.24 billion and...
Read More
Press Release Jul 21, 2014
READING, UK – July 21, 2014 – Quintiles has been recognized for its commitment to employee health and wellness, taking the 2014 “Britain’s Healthiest Workplace” award at a ceremony addressed by Dame Carol Black and Lord Sebastian Coe. Britain’s Healthiest Company aims to celebrate organizations that have an outstanding approach to their employees’ health and wellbeing and is the UK’s largest survey into employee health. In 2014 more than 80 companies were surveyed on criteria including facilities, culture and work environment. Quintiles UK Head Lindy Jones said, “Our work on developing and commercializing medicines means that every day we are focused on improving the lives of people in the UK and beyond. A proactive approach to health and wellbeing is integral to living a full and healthy...
Read More
Press Release Jun 23, 2014
RESEARCH TRIANGLE PARK, N.C. – June 23, 2014 – Quintiles, the world’s largest biopharmaceutical services provider and a Fortune 500 company, has been named one of IDG Computerworld's 100 Best Places to Work in IT 2014, the sixth time it has received this employer distinction over the past seven years. Computerworld has ranked the top 100 work environments for technology professionals at U.S. companies or U.S. staff of international companies each year since 1994. The list is compiled each year based on company offerings in categories such as benefits, career development, training and retention. In addition, Computerworld conducts extensive surveys of IT workers with their responses factoring heavily in determining the rankings. “We are delighted to be named for the sixth time as one of...
Read More